|1.||Horváth, Tamás: 1 article (03/2015)|
|2.||Hüttl, Kálmán: 1 article (03/2015)|
|3.||Merkely, Béla: 1 article (03/2015)|
|4.||Maurovich-Horvat, Pál: 1 article (03/2015)|
|5.||Major, Gyöngyi P: 1 article (03/2015)|
|6.||Szilveszter, Bálint: 1 article (03/2015)|
|7.||Csobay-Novák, Csaba: 1 article (03/2015)|
|8.||Suhai, Ferenc I: 1 article (03/2015)|
|9.||Jermendy, Ádám L: 1 article (03/2015)|
|10.||Bartykowszki, Andrea: 1 article (03/2015)|
|1.||Body Weight (Weight, Body)
01/01/2015 - "Lung carcinogenesis was induced by a single intra-peritoneal (IP) injection of BP (100 mg/kg body weight). "
01/01/2013 - "In the derivation sample, multivariable analyses produced the risk score, which contained six variables: age > 80 years, heart rate ≥ 110/min, systolic BP < 100 mm Hg, body weight < 60 kg, recent immobility, and presence of metastases. "
02/01/2015 - "The aim of the present study was to assess the cumulative effects of curcumin and quercetin in inducing apoptosis during benzo(a)pyrene (BP) (100 mg/Kg body weight)-induced lung carcinogenesis in mice. "
01/01/1984 - "dose of benzo[a]pyrene (BP) (100 mg/kg body weight) with or without pretreatment with beta-naphthoflavone (BNF), an inducer of monooxygenases. "
|3.||Hypotension (Low Blood Pressure)
02/01/2014 - "The duration of hypotension (mean systolic BP <100 mm Hg) during baseline accounted for 7.1% of the recording. "
01/01/1998 - "There was no first-dose hypotension (systolic BP < 100 mmHg). "
07/01/1994 - "In the 180 patients studied retrospectively, we found that 61% of patients with prehospital hypotension (BP < 100 mm Hg) required transfusion, whereas only 11% of patients without prehospital hypotension required transfusion (P < .0001). "
09/01/1993 - "Patients were identified who: (a) met the blood pressure (BP) criteria for first-dose hypotension (sitting or standing systolic BP < 100 mmHg, or a fall in systolic BP > or = 20 mmHg on standing); (b) had symptoms suggestive of hypotension; and (c) met the BP criteria and had symptoms. "
03/01/2015 - "Of note, hypotension (systolic BP <100 mm Hg) was observed right after the scan in 19 patients (9.3%) in the esmolol group and in 8 patients (3.8%) in the metoprolol group (P < .05), whereas only 5 patients (2.5%) had hypotension 30 minutes after the scan in the esmolol group compared to 8 patients (3.8%) in the metoprolol group (P = .418). "
|4.||Hypertension (High Blood Pressure)
09/01/2012 - "Compared with patients with sustained hypertension, more patients in the white-coat hypertension group had low nocturnal average systolic BP (defined as nocturnal average systolic BP <100 mm Hg) (17.4% vs 0%) and low 24-hour average diastolic BP (defined as 24-hour average diastolic BP <60 mm Hg) (52.2% vs 22%, P<.01). "
11/01/2008 - "Main outcome-of-interest was incident severe hypertension (systolic blood pressure [BP] 160 mmHg or above, diastolic BP 100 mmHg or above, or a combination of self-reported hypertension diagnosis and use of antihypertensive medications) among baseline individuals without severe hypertension. "
12/01/1988 - "In 40 patients with mild to moderate hypertension 24-h blood pressure was monitored simultaneously with the ABPM 630 and BP-100. "
06/02/1973 - "The prevalence of individuals with probable essential hypertension (diastolic BP > 100 mm. Hg) in individuals over 50 years of age was found to be three times higher in the island community, Fogo, than in Badger. "
01/01/2005 - "Patients (n=145, 53 men and 92 women, age 40-75 years) with untreated stage 1 hypertension (systolic BP 140-159 and diastolic BP <100 mm Hg) and excessive weight or obesity (body mass index >27 kg/m(2)) were divided into 2 groups: with (group 1, n=124) and without (group II, n=21) disturbances of carbohydrate metabolism. "
|5.||Coronary Disease (Coronary Heart Disease)
01/01/2001 - "A total of 204 patients were screened and of these 110 were diagnosed as mild to moderately hypertensive with clinic diastolic BP 100-110 mm Hg (> or =95 mm Hg in patients with coronary heart disease risk factors). "
09/01/1999 - "Initiate antihypertensive drug therapy in people with sustained systolic blood pressures (BP) >/=160 mm Hg or sustained diastolic BP >/=100 mm Hg. Decide on treatment in people with sustained systolic BP between 140 and 159 mm Hg or sustained diastolic BP between 90 and 99 mm Hg according to the presence or absence of target organ damage, cardiovascular disease or a 10-year coronary heart disease (CHD) risk of >/=15% according to the Joint British Societies CHD risk assessment programme/risk chart. "
|10.||Mixed Function Oxygenases (Monooxygenases)
|1.||Drug Therapy (Chemotherapy)